Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Winglee

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Nutrition and Dietary Supplements|July 11, 2017
Intrinsic association between diet and the gut microbiome: current evidenceKathryn Winglee, Anthony A Fodor
Nature Protocols|May 18, 2013
Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafishKevin Takaki, J Muse Davis, Kathryn Winglee, et al.
The Journal of Pathology|January 19, 2017
Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosisShashank Gupta, Kathryn Winglee, Richard Gallo, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2015
Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis resistance to an imidazopyridine-based agentKathryn Winglee, Shichun Lun, Marco Pieroni, et al.
Emerging Infectious Diseases|March 23, 2022
Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020Kathryn Winglee, Andrew N Hill, Adam J Langer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2022
Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United StatesKathryn Winglee, Andrew N Hill, Robert Belknap, et al.
Plos One|May 14, 2014
Aerosol Mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiotaKathryn Winglee, Emiley Eloe-Fadrosh, Shashank Gupta, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2013
Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosisShashank Gupta, Keira A Cohen, Kathryn Winglee, et al.
Public Health Reports (Washington, D.C. : 1974)|June 5, 2026
Time to Progress Through the Latent Tuberculosis Infection Care Cascade in Primary CareAngus Zhuo-Long Wu, Kaylynn Aiona, Matthew Murrill, et al.
The Journal of Infectious Diseases|April 5, 2012
Risk of tuberculosis reactivation with tofacitinib (CP-690550)Mamoudou Maiga, Shichun Lun, Haidan Guo, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Nutrition and Dietary Supplements|July 11, 2017
Intrinsic association between diet and the gut microbiome: current evidenceKathryn Winglee, Anthony A Fodor
Nature Protocols|May 18, 2013
Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafishKevin Takaki, J Muse Davis, Kathryn Winglee, et al.
The Journal of Pathology|January 19, 2017
Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosisShashank Gupta, Kathryn Winglee, Richard Gallo, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2015
Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis resistance to an imidazopyridine-based agentKathryn Winglee, Shichun Lun, Marco Pieroni, et al.
Emerging Infectious Diseases|March 23, 2022
Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020Kathryn Winglee, Andrew N Hill, Adam J Langer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2022
Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United StatesKathryn Winglee, Andrew N Hill, Robert Belknap, et al.
Plos One|May 14, 2014
Aerosol Mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiotaKathryn Winglee, Emiley Eloe-Fadrosh, Shashank Gupta, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2013
Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosisShashank Gupta, Keira A Cohen, Kathryn Winglee, et al.
Public Health Reports (Washington, D.C. : 1974)|June 5, 2026
Time to Progress Through the Latent Tuberculosis Infection Care Cascade in Primary CareAngus Zhuo-Long Wu, Kaylynn Aiona, Matthew Murrill, et al.
The Journal of Infectious Diseases|April 5, 2012
Risk of tuberculosis reactivation with tofacitinib (CP-690550)Mamoudou Maiga, Shichun Lun, Haidan Guo, et al.
Pageof 5